SEC Filing Details
Document Details
Form
Filing Date
Jun 7, 2019
Document Date
Jun 3, 2019
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.
Filer
Hindman Andrew A.